From: Wilms tumor 1 gene expression in acute myeloid leukemia: prognostic significance and usefulness in minimal residual disease monitoring—a case–control study
Overall survival (OS)
WT1 level of expression
< 15 months (n = 27)
≥ 15 months (n = 13)
χ2
FEp
No
%
WT1-Positive (n = 35)
26
74.3
9
25.7
5.877*
0.031*
WT1-Negative (n = 5)
1
20.0
4
80.0